COVID-19 UPDATE: Click here for current news.
The Rx Consultant

Non Subscriber: Add to Cart

Managing Colds and Cough in Children

Clicking the "View this Article" button will open the issue as a resizable PDF. To take the test for the issue, return to this Introduction page and click the "Take the Test" button. The Introduction page will remain open after you open this issue.
You may need to re-size or close the issue in order to see the Introduction page.

Overview

Children often suffer from viral upper respiratory infections or “the common cold,” with symptoms of congestion, rhinorrhea (runny nose), cough and fever. Children typically experience 3 to 8 colds per year. Colds have a substantial impact on school attendance, resulting in an estimated 189 million days of absence each year. Considering children and adults together, colds account for $17 billion in direct medical costs and $22.5 billion in indirect costs (including absenteeism and missed caregiver work days) annually in the US.

Colds are usually self-limiting, but non-drug measures and over-the-counter (OTC) medications may relieve bothersome symptoms. Although many OTC medications are recognized as safe and effective in the FDA's OTC monograph,clinical trial evidence in pediatric patients is often limited. In 2001, concerns escalated about serious adverse effects and deaths among infants and young children related to cough and cold medications. These reports led to a 2008 decision by the FDA to provide guidance that cough and cold products should be avoided in children under the age of 2 years.

Details

Publication Date: 10/22/2020
Expiration Date: 10/22/2023
CE Credit: 1.5 (0.15 CEU)
Type of Activity: Knowledge-based

This program was developed by The Rx Consultant and published by Continuing Education Network, Inc. The Rx Consultant accepts no advertising or financial support from the pharmaceutical industry and is funded solely by the purchase of programs. The Rx Consultant is dedicated to providing unbiased, balanced information to health care practitioners.

Programs developed by The Rx Consultant are written by health care providers with expertise in the topic area, peer-reviewed, extensively edited, and fact-checked. This development process was created to insure that every program presents information that is current, accurate, relevant to "real world" health care providers, and written in an easy reading, "plain English" style.

Authors

Courtney L. Bradley, PharmD,BCACP is an Assistant Professor and Applied Laboratory Coordinator at High Point University Fred Wilson School of Pharmacy in High Point, NC.She practices as a community pharmacist at an independent pharmacy.

Kelly L. Scolaro, PharmD is an Associate Professor at LECOM School of Pharmacy,Brandenton, FL. She provides ambulatory care services to patients at Turning Points Clinic (Bradenton, FL) and Good Samaritan Pharmacy and Health Services (Nokomis, FL).

Disclosure Statement

Dr. Bradley and Dr. Scolaro reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.

Target Audience

This accredited program is targeted to pharmacists .

Goals & Objectives

At the conclusion of this program, participants will be able to:

    1. Differentiate among symptoms of the common cold, influenza, allergy, and COVID-19. Identify which children with a cold, cough, and/or fever should be referred to a primary care provider for further assessment.
    2. Discuss nonprescription medications used for the treatment of specific cough and cold symptoms in children; include age-appropriate dosing and potential side effects.
    3. Recommend non-drug strategies for managing and preventing colds to a parent or caregiver. Discuss the use of alternative or complementary remedies for treating or preventing colds in children.

Accreditation Statements

The Rx Consultant is a publication of Continuing Education Network, Inc.

ACPE logo
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education as a provider of continuing pharmacy education.

California Board of Registered Nursing logo
Continuing Education Network is approved by the California Board of Registered Nursing, Provider Number CEP 13118. Programs approved by CA BRN are accepted by most State Boards of Nursing.

ACPE Universal Activity Number: 0428-0000-20-010-H01-P


Exam & Credit Statement Procedures

Upon successful completion of this program and the post test (70%), 1.5 hours of continuing education credit will be awarded. To receive credit and your exam score, please complete the exam questions and program evaluation.

Editorial and Review Board

Chief Editor and CE Administrator


Terry M. Baker, PharmD

Managing Editor


Tracy Farnen, PharmD

Associate Editors


James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Coordinator
Kaiser Permanente
Oakland, CA

Associate Clinical Professor
School of Pharmacy
University of California San Francisco
San Francisco, CA

Richard Ron Finley, B.S. Pharm.,R.Ph.
Clinical Pharmacist (volunteer faculty)
University of California, San Francisco (UCSF) Memory and Aging Center
Lecturer (Emeritus) UCSF, Department of Clinical Pharmacy
Health Sciences Clinical Professor, UCSF School of Pharmacy
San Francisco, CA

Consultant Pharmacist
Ray Dolby Brain Health Center, Sutter Health/CPMC
San Francisco, CA

Consult Pharmacist Aging and Adult Health Services
San Francisco Health Department
San Francisco, CA

Julio R. Lopez, PharmD, FCSHP
Chief of Pharmacy Service
VA Northern California Health Care System

Adjunct Clinical Professor
College of Pharmacy
Touro University
Vallejo, CA

Assistant Clinical Professor
School of Pharmacy
University of California, San Francisco
San Francisco, CA Adjunct Professor
Thomas J. Long School of Pharmacy
University of the Pacific
Stockton, CA

Visiting Associate Professor and Lecturer
Nursing School
Samuel Merritt University
Oakland, CA

Pamela Mausner, MD

Helen Berlie, Pharm.D. CDE, BCACP
Clinical Assistant Professor, Pharmacy Practice
Wayne State University
Detroit, MI

Ambulatory Care Specialist - Diabetes
Health Centers Detroit Medical Group
Detroit, MI

Senior Editorial Advisor


Gerard Hatheway, PharmD, PhD

Editorial Advisors


Belinda M. Danielson, RPh
Christopher M. DeSoto, PharmD
Angie S. Graham, PharmD
Cynthia Chan Huang, PharmD, MBA
Fred Plageman, PharmD

Editorial Advisor and Clinical Practice Consultant for Nurse Practitioners


Emily K.
Meuleman, RN, C, MS

About the Rx Consultant

The Rx Consultant is a monthly publication dedicated to providing health care professionals with the information they need to educate patients about drugs and manage drug therapy. The reader is responsible for confirming the information presented here and interpreting it in relation to each patient's specific situation before utilizing the information.

Technical Specifications

Hardware requirements

Any hardware that supports Microsoft Windows, Apple Mac OS, iOS, or Android, and meets the software requirements.

Software requirements

Browser that supports TLS 1.1 + and PDF files.

This includes Microsoft Internet Explorer 11, Google Chrome 38, Google Android OS 5.0 Browser, Apple Safari (version 7 for desktop, 5 for mobile), Mozilla Firefox 27, newer versions of these browsers, as well as some earlier versions that may require additional configuration.

Adobe Acrobat Reader is recommended, and is required for some browsers.

Note: TLS 1.1 and 1.2 support is required for browser security. Click here for TLS browser support details.

Internet Connectivity

Required. Broadband recommended. (T1, DSL, Cable, G4 or higher.)

Contact Us

Exam Processing Inquiries

The Rx Consultant
rxmail@rxconsultant.com
1-800-798-3353

Educational Content Inquiries

The Rx Consultant
editor@rxconsultant.com
1-800-798-3353

Non Subscriber: Add to Cart